Loading…

Synthesis and Photophysics of Water‐Soluble Psoralens with Red‐Shifted Absorption

8‐Methoxypsoralen (8‐MOP) serves as a PUVA (psoralen + UV‐A) agent in the treatment of certain skin diseases. Derivatives of 8‐MOP with cationic aromatic substituents at the five positions were synthesized and characterized by steady‐state, femtosecond and nanosecond spectroscopy as well as cyclic v...

Full description

Saved in:
Bibliographic Details
Published in:Photochemistry and photobiology 2021-11, Vol.97 (6), p.1534-1547
Main Authors: Bertling, Janina, Thom, Kristoffer A., Geenen, Sarah, Jeuken, Hannah, Presser, Lysander, Müller, Thomas J. J., Gilch, Peter
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:8‐Methoxypsoralen (8‐MOP) serves as a PUVA (psoralen + UV‐A) agent in the treatment of certain skin diseases. Derivatives of 8‐MOP with cationic aromatic substituents at the five positions were synthesized and characterized by steady‐state, femtosecond and nanosecond spectroscopy as well as cyclic voltammetry. The aromatic substituents' positive charge increases the water solubility and the affinity toward intercalation into DNA. The aromatic substituents were supposed to lower the psoralen S1 energy and thereby suppress a photo‐induced electron transfer (PET) with guanine‐bearing DNA. Such a suppression of this PET is expected to increase the propensity of psoralens to photo‐addition to DNA. For derivatives bearing methylpyridinium residues, femtosecond spectroscopy revealed an intramolecular PET occurring on the picosecond time scale. This PET precludes the population of the triplet state. As triplet states are the precursor state for the photo‐addition to DNA, their intermolecular PET renders these derivatives ineffective in terms of PUVA. For two derivatives bearing trimethylphenylammonium moieties, such an intramolecular PET does not occur and the triplet state is populated. Surprisingly, these compounds also exhibit no PUVA activity. Based on these findings, implications for further optimization of PUVA agents are discussed. 8‐Methoxypsoralen (8‐MOP) serves as a PUVA (psoralen + UV‐A) agent in the treatment of certain skin diseases. Derivatives of 8‐MOP with cationic aromatic substituents at the 5 positions were synthesized and characterized by steady‐state and time‐resolved spectroscopy as well as cyclic voltammetry. The aromatic substituents were supposed to lower the psoralen S1 energy and thereby suppress a photo‐induced electron transfer (PET) with guanine‐bearing DNA. Such a suppression of this PET is expected to increase the propensity of psoralens to photo‐addition to DNA.
ISSN:0031-8655
1751-1097
DOI:10.1111/php.13480